The protection by NF-κB is due to transcriptional activation of a number of antiapoptotic proteins, such as Bcl-2 and Bcl-XL [12,13].Therefore, targeting NF-κB signaling pathway could result in improved prognoses through increased apoptosis in AP. The gene discussed is BCL2; the disease is alkaline phosphatase measurement.